| Serial Number | 88377819 |
| Word Mark | MIQURE |
| Filing Date | Tuesday, April 9, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 1, 2021 |
| Registration Number | 6367204 |
| Registration Date | Tuesday, June 1, 2021 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 16, 2021 |
| Goods and Services | Medicinal preparations for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; Pharmaceutical preparations and substances for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the diagnosis, treatment or prevention of Central Nervous System diseases, Liver diseases, Neuromuscular diseases and Cardiovascular diseases |
| Goods and Services | Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics |
| Goods and Services | Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, April 25, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | UNIQURE BIOPHARMA B.V. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 26 - NOT AVAILABLE |
| Address | AMSTERDAM 1105BP NL |
| Party Name | uniQure IP B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Party Name | uniQure IP B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Party Name | uniQure IP B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BP NL |
| Event Date | Event Description |
| Friday, April 12, 2019 | NEW APPLICATION ENTERED |
| Thursday, April 25, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 19, 2019 | ASSIGNED TO EXAMINER |
| Monday, June 24, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, June 24, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, June 24, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 25, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 4, 2019 | ASSIGNED TO LIE |
| Wednesday, December 4, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 4, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 5, 2019 | SUSPENSION LETTER WRITTEN |
| Thursday, December 5, 2019 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 5, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, February 2, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 11, 2020 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, January 28, 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, February 2, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 2, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 2, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 2, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 5, 2021 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, February 8, 2021 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, February 24, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 16, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 16, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 1, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Friday, May 26, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, May 26, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, May 26, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, May 26, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, May 26, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, May 26, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, May 26, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, June 4, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, June 4, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 4, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, June 4, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, June 4, 2025 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, June 4, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, June 11, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, June 4, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |